Mary Jo Trepka1, Kristopher P Fennie1, Valerie Pelletier1, Khaleeq Lutfi1, Spencer Lieb1, Lorene M Maddox1. 1. From the Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, the AIDS Institute/Florida Consortium for HIV/AIDS Research, Tampa, and the HIV/AIDS and Hepatitis Section, Florida Department of Health, Tallahassee.
Abstract
OBJECTIVES: To characterize migration patterns among people diagnosed as having and who died of acquired immunodeficiency syndrome (AIDS) from 1993 to 2007 because migrating to a new community can disrupt human immunodeficiency virus/AIDS care delivery and patients' adherence to care and affect migrants' social services and healthcare needs. METHODS: Florida AIDS surveillance data were used to describe patterns of migration among people diagnosed as having and who died of AIDS from 1993 to 2007. Individual and community characteristics were compared between residence at the time of AIDS diagnosis and residence at the time of death by type of migration. RESULTS: Of 31,816 people in the cohort, 2510 (7.9%) migrated to another county in Florida and 1306 (4.1%) migrated to another state. Interstate migrants were more likely to be men, 20 to 39 years old, non-Hispanic white, and born in the United States, to have had a transmission mode of injection drug use (IDU) or men who have sex with men with IDU (MSM&IDU), and to have been diagnosed before 1999. Intercounty migrants were more likely to be non-Hispanic white, younger than 60 years, have had a transmission mode of MSM, IDU, or MSM&IDU, have higher CD4 counts/percentages, and to have lived in areas with low levels of poverty or low physician density. There was a small net movement from urban to rural areas within the state. CONCLUSIONS: A sizable percentage of people, particularly younger people and people with a transmission mode of IDU and IDU&MSM, migrated at least once between the time of their AIDS diagnosis and death. This has important implications for care and treatment, as well as efforts to prevent the disease. Further research is needed to explore barriers and facilitators to access to care upon migration and to assess the need for programs to help people transfer their human immunodeficiency virus/AIDS care, ensuring continuity of care and adherence.
OBJECTIVES: To characterize migration patterns among people diagnosed as having and who died of acquired immunodeficiency syndrome (AIDS) from 1993 to 2007 because migrating to a new community can disrupt human immunodeficiency virus/AIDS care delivery and patients' adherence to care and affect migrants' social services and healthcare needs. METHODS: Florida AIDS surveillance data were used to describe patterns of migration among people diagnosed as having and who died of AIDS from 1993 to 2007. Individual and community characteristics were compared between residence at the time of AIDS diagnosis and residence at the time of death by type of migration. RESULTS: Of 31,816 people in the cohort, 2510 (7.9%) migrated to another county in Florida and 1306 (4.1%) migrated to another state. Interstate migrants were more likely to be men, 20 to 39 years old, non-Hispanic white, and born in the United States, to have had a transmission mode of injection drug use (IDU) or men who have sex with men with IDU (MSM&IDU), and to have been diagnosed before 1999. Intercounty migrants were more likely to be non-Hispanic white, younger than 60 years, have had a transmission mode of MSM, IDU, or MSM&IDU, have higher CD4 counts/percentages, and to have lived in areas with low levels of poverty or low physician density. There was a small net movement from urban to rural areas within the state. CONCLUSIONS: A sizable percentage of people, particularly younger people and people with a transmission mode of IDU and IDU&MSM, migrated at least once between the time of their AIDS diagnosis and death. This has important implications for care and treatment, as well as efforts to prevent the disease. Further research is needed to explore barriers and facilitators to access to care upon migration and to assess the need for programs to help people transfer their human immunodeficiency virus/AIDS care, ensuring continuity of care and adherence.
Authors: Adaora A Adimora; Victor J Schoenbach; Eboni M Taylor; Maria R Khan; Robert J Schwartz Journal: Am J Public Health Date: 2010-08-19 Impact factor: 9.308
Authors: A Lansky; A K Nakashima; T Diaz; S A Fann; L Conti; M Herr; D Smith; J Karon; J L Jones; J W Ward Journal: J Rural Health Date: 2000 Impact factor: 4.333
Authors: Sandra Schwarcz; Susan Scheer; Willi McFarland; Mitchell Katz; Linda Valleroy; Sanny Chen; Joseph Catania Journal: Am J Public Health Date: 2007-04-26 Impact factor: 9.308
Authors: Diana M Sheehan; Mary Jo Trepka; Kristopher P Fennie; Guillermo Prado; Purnima Madhivanan; Frank R Dillon; Lorene M Maddox Journal: Drug Alcohol Depend Date: 2015-07-16 Impact factor: 4.492